Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Bednar

Showing results (111-120 of 146) with videos related to

Pageof 15
Sort By:
Gynecologic Oncology|December 12, 2018
Disseminating universal genetic testing to a diverse, indigent patient population at a county hospital gynecologic oncology clinicErica M Bednar, Charlotte C Sun, Bethsaida Camacho, et al.
The Journal of Hand Surgery|November 6, 2020
ASSH 75 Years: An Update of Progress Over the Past 25 YearsJoshua M Abzug, John M Bednar, Marybeth Ezaki, et al.
ACS Applied Materials & Interfaces|September 19, 2019
Immobilization of Proteins with Controlled Load and OrientationRiley M Bednar, Thaddeus W Golbek, Kelsey M Kean, et al.
International Journal of Clinical Pharmacology and Therapeutics|October 18, 2013
Safety and pharmacokinetics of PF-04360365 following a single-dose intravenous infusion in Japanese subjects with mild-to-moderate Alzheimer's disease: a multicenter, randomized, double-blind, placebo-controlled, dose-escalation studyIzuru Miyoshi, Yoko Fujimoto, Masahito Yamada, et al.
Alzheimer'S & Dementia (New York, N. Y.)|October 26, 2017
Ponezumab in mild-to-moderate Alzheimer's disease: Randomized phase II PET-PIB studyJaren W Landen, Niels Andreasen, Carol L Cronenberger, et al.
Critical Pathways in Cardiology|February 15, 2014
Lessons in flying: crew resource management as a quality improvement method for acute coronary syndromes carePhillip D Levy, Janeen N Dancy, Stephanie A Stowell, et al.
Clinical Neuropharmacology|January 22, 2013
Safety and pharmacology of ponezumab (PF-04360365) after a single 10-minute intravenous infusion in subjects with mild to moderate Alzheimer diseaseAaron H Burstein, Qinying Zhao, Joel Ross, et al.
AJR. American Journal of Roentgenology|January 24, 2002
Limitations of MR imaging in the diagnosis of peripheral tears of the triangular fibrocartilage of the wristAndrew H Haims, Mark E Schweitzer, William B Morrison, et al.
British Journal of Clinical Pharmacology|May 15, 2021
Safety, pharmacokinetics and pharmacodynamics of TAK-418, a novel inhibitor of the epigenetic modulator lysine-specific demethylase 1AWei Yin, Dimitrios Arkilo, Polyna Khudyakov, et al.
Journal of Molecular Biology|June 23, 2020
Overcoming Near-Cognate Suppression in a Release Factor 1-Deficient Host with an Improved Nitro-Tyrosine tRNA SynthetaseJenna N Beyer, Parisa Hosseinzadeh, Ilana Gottfried-Lee, et al.
Pageof 15

Showing results (111-120 of 146) with videos related to

Sort By:
Pageof 15
Gynecologic Oncology|December 12, 2018
Disseminating universal genetic testing to a diverse, indigent patient population at a county hospital gynecologic oncology clinicErica M Bednar, Charlotte C Sun, Bethsaida Camacho, et al.
The Journal of Hand Surgery|November 6, 2020
ASSH 75 Years: An Update of Progress Over the Past 25 YearsJoshua M Abzug, John M Bednar, Marybeth Ezaki, et al.
ACS Applied Materials & Interfaces|September 19, 2019
Immobilization of Proteins with Controlled Load and OrientationRiley M Bednar, Thaddeus W Golbek, Kelsey M Kean, et al.
International Journal of Clinical Pharmacology and Therapeutics|October 18, 2013
Safety and pharmacokinetics of PF-04360365 following a single-dose intravenous infusion in Japanese subjects with mild-to-moderate Alzheimer's disease: a multicenter, randomized, double-blind, placebo-controlled, dose-escalation studyIzuru Miyoshi, Yoko Fujimoto, Masahito Yamada, et al.
Alzheimer'S & Dementia (New York, N. Y.)|October 26, 2017
Ponezumab in mild-to-moderate Alzheimer's disease: Randomized phase II PET-PIB studyJaren W Landen, Niels Andreasen, Carol L Cronenberger, et al.
Critical Pathways in Cardiology|February 15, 2014
Lessons in flying: crew resource management as a quality improvement method for acute coronary syndromes carePhillip D Levy, Janeen N Dancy, Stephanie A Stowell, et al.
Clinical Neuropharmacology|January 22, 2013
Safety and pharmacology of ponezumab (PF-04360365) after a single 10-minute intravenous infusion in subjects with mild to moderate Alzheimer diseaseAaron H Burstein, Qinying Zhao, Joel Ross, et al.
AJR. American Journal of Roentgenology|January 24, 2002
Limitations of MR imaging in the diagnosis of peripheral tears of the triangular fibrocartilage of the wristAndrew H Haims, Mark E Schweitzer, William B Morrison, et al.
British Journal of Clinical Pharmacology|May 15, 2021
Safety, pharmacokinetics and pharmacodynamics of TAK-418, a novel inhibitor of the epigenetic modulator lysine-specific demethylase 1AWei Yin, Dimitrios Arkilo, Polyna Khudyakov, et al.
Journal of Molecular Biology|June 23, 2020
Overcoming Near-Cognate Suppression in a Release Factor 1-Deficient Host with an Improved Nitro-Tyrosine tRNA SynthetaseJenna N Beyer, Parisa Hosseinzadeh, Ilana Gottfried-Lee, et al.
Pageof 15